Kenji Inui

Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody.

Fumihiro Tanaka, Yosuke Otake, Kazuhiro Yanagihara et al. · PubMed · 2001 · 275 citations

Medicine, Oncology, Pathology +12

Surgical treatment for invasive thymoma, especially when the superior vena cava is invaded

Kazuyuki Yagi, Toshiki Hirata, Tatsuo Fukuse et al. · The Annals of Thoracic Surgery · 1996 · 114 citations

Medicine, Oncology, Surgery +9

Prognostic significance of polysialic acid expression in resected non-small cell lung cancer.

Fumio Tanaka, Yosuke Otake, Tatsuo Nakagawa et al. · PubMed · 2001 · 76 citations

Medicine, Cancer Biology, Oncology +14

Clinical significance of caspase-3 expression in pathologic-stage I, nonsmall-cell lung cancer

Tetsuya Takata, Fumihiro Tanaka, Tomoko Yamada et al. · International Journal of Cancer · 2001 · 48 citations · Full text

Life Sciences, Oncology, Pathology +11

Prognostic factors in patients with resected pathologic (p-) T1-2N1M0 non-small cell lung cancer (NSCLC)

Fumihiro Tanaka, Kazuhiro Yanagihara, Yosuke Otake et al. · European Journal of Cardio-Thoracic Surgery · 2001 · 47 citations · Full text

Medicine, Oncology, Pathology +17